Cost-effectiveness of combining finerenone and sodium-glucose cotransporter 2 inhibitors with standard of care for patients with chronic kidney disease and type 2 diabetes in China.

Saved in:
Bibliographic Details
Title: Cost-effectiveness of combining finerenone and sodium-glucose cotransporter 2 inhibitors with standard of care for patients with chronic kidney disease and type 2 diabetes in China.
Authors: Hu, Zhengqiang1 (AUTHOR), Jin, Wei1 (AUTHOR), Lou, Shengying1 (AUTHOR), Zhang, Lejun2 (AUTHOR) 21718604@zju.edu.cn
Source: Renal Failure. Dec2025, Vol. 47 Issue 1, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:0886022X
DOI:10.1080/0886022X.2025.2578413